The group’s principle activity is to provide therapy solutions restoring regenerative wound healing capacity impaired by disease, trauma or other factors. The group’s products include EpiFLO(TM), Transdermal Sustained Oxygen Therapy and EpiFLO(SD). The group operates from United States.
